Leukemia charity invests $3.7 million for trial network

Thursday, May 19, 2011 10:42 AM

Leukemia & Lymphoma Research, a U.K. charity, is investing $3.7 million in a national network of clinical trial centers to improve chances of survival for people suffering from leukaemia, lymphoma and myeloma.

The network will centered at University of Birmingham and connect 13 hospitals in Southampton, London, Manchester, Leeds, Birmingham, Belfast Glasgow, Liverpool, Cardiff, Oxford and Nottingham.

The charity is working with pharmaceutical companies and the National Health Service hospitals to bring up to $80 million of new drugs to patients through the network over the next two years.

The trials will create as many as 500 jobs are expected to begin by the end of 2011.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs